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Ai Kubo1, Gladys Block2, Charles P Quesenberry Jr1, Patricia Buffler2 and Douglas A Corley1*Abstract
Background: Gastroesophageal reflux disease (GERD) is the most common gastrointestinal disease, and the cost of
health care and lost productivity due to GERD is extremely high. Recently described side effects of long-term acid
suppression have increased the interest in nonpharmacologic methods for alleviating GERD symptoms. We aimed
to examine whether GERD patients follow recommended dietary guidelines, and if adherence is associated with the
severity and frequency of reflux symptoms.
Methods: We conducted a population-based cross-sectional study within the Kaiser Permanente Northern California
population, comparing 317 GERD patients to 182 asymptomatic population controls. All analyses adjusted for
smoking and education.
Results: GERD patients, even those with moderate to severe symptoms or frequent symptoms, were as likely to
consume tomato products and large portion meals as GERD-free controls and were even more likely to consume
soft drinks and tea [odds ratio (OR) = 2.01 95% confidence interval (CI) 1.12-3.61; OR = 2.63 95% CI 1.24-5.59,
respectively] and eat fried foods and high fat diet. The only reflux-triggering foods GERD patients were less likely to
consume were citrus and alcohol [OR = 0.59; 95% CI: 0.35-0.97 for citrus; OR = 0.41 95% CI 0.19-0.87 for 1 + drink/day
of alcohol]. The associations were similar when we excluded users of proton pump inhibitors.
Conclusions: GERD patients consume many putative GERD causing foods as frequently or even more frequently
than asymptomatic patients despite reporting symptoms. These findings suggest that, if dietary modification is
effective in reducing GERD, substantial opportunities for nonpharmacologic interventions exist for many GERD
patients.
Keywords: Gastroesophageal reflux, Heartburn, DietBackground
Gastroesophageal reflux disease (GERD) is one of the
most common illnesses in the United States. The preva-
lence of diagnosed GERD cases is estimated to be 13-19%
worldwide [1] and about 25% of the Western population
suffers from heartburn or acid regurgitation at least once
per month; 12% have symptoms at least weekly and 5% ex-
perience heartburn daily [2]. Symptoms associated with
GERD include heartburn, acid regurgitation, dysphagia
(difficulty in swallowing), and chest pain, as well as extrae-
sophageal manifestations such as nausea, chronic cough,
asthma, and hoarseness [3,4].* Correspondence: douglas.corley@kp.org
1Kaiser Permanente Division of Research, University of California, San
Francisco, 2000 Broadway, Oakland, CA 94612, USA
Full list of author information is available at the end of the article
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reproduction in any medium, provided the orThe financial burden of disease from GERD is high;
much of this is for anti-acid medications. The cost of
health care and lost productivity due to GERD is estimated
at over $24 billion annually in the US alone [5-7], 60% of
which is used for medication [8]. The annual average med-
ical costs and services for patients with GERD may be
twice that of the non-GERD population due to additional
outpatient visits, hospitalizations, emergency department
utilization, and pharmacy costs [5]. In addition, the quality
of life in GERD patients is also compromised: the impact
of GERD on quality of life measures is similar to that of
other chronic diseases such as diabetes, heart failure, or
ischemic heart disease [9].
Newly recognized potential adverse effects of acid
suppression have heightened the interest in nonphar-
macologic approaches for GERD treatment in personstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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what between studies, acid suppression has been re-
cently associated with decreased absorption of dietary
calcium and calcium supplements [10,11], an increased
risk of hip fractures [12-14], food borne infections, and
an increased risk of clostridium difficile infection
[15,16]. These findings led to a recent modification in
the labeling of proton pump inhibitors to include con-
cerns about an increased risk of hip fracture and a
search for methods to decrease GERD patients’ reliance
on pharmacologic methods of acid suppression.
Dietary modification is a proposed first-line therapy
for patients with GERD. The National Institutes of
Health and the American College of Gastroenterology
recommend that patients with GERD reduce their in-
takes of total fat, chocolate, alcohol, citrus and tomato
products, coffee, tea, and large meals, and implement
other lifestyle changes such as stopping smoking and
weight reduction [17,18]. However, no previous population-
based study has evaluated what proportions of GERD pa-
tients actually follow these dietary guidelines. Therefore, we
evaluated, within a large community-based population, the
associations between a GERD diagnosis, reflux symptoms
and dietary intake. We hypothesized that patients with
more severe or frequent symptoms were less likely to
adhere to the dietary modification recommendations.
Methods
Study population
We performed an analysis of a case–control study of
Barrett’s esophagus; the study recruited members of the
Kaiser Permanente, Northern California (KPNC) popula-
tion, an integrated health services delivery organization,
between 2002 and 2005. The KPNC membership contains
approximately 3.3 million persons whose demographics
closely approximate the underlying census population of
Northern California [17,18]. The study included Barrett’s
esophagus patients as cases and two sex and age-matched
control groups: GERD patients and population controls.
The details of this original study were described previously
in detail [19]. The present analysis contrasts the GERD
and population control groups. The study and analyses
were approved by the KPNC institutional review board
and were performed in accordance with the Declaration of
Helsinki. Informed consent was obtained.
GERD patients
GERD patients consisted of 317 eligible KPNC members
who were selected from among all individuals with a
physician-assigned GERD diagnosis (e.g. ICD-9 codes
530.11 reflux esophagitis and 530.81 gastroesophageal
reflux) who also had a prescription for at least 90 days
supply of anti-secretory medications and no diagnosis of
Barrett’s esophagus (any visible columnar metaplasia)from an esophagogastroduodenoscopy close to the index
date. Endoscopy and pathology reports were manually
reviewed. The validity of identifying GERD patients
using encounter and pharmacy databases was previously
evaluated in a 100,000 member managed care organization
[20]. All patients in the current study also ultimately re-
ceived questionnaires regarding GERD symptoms and
actual medication use.
Exposure to anti-secretory medications utilized a phar-
macy database with information on prescription type,
frequency of dispensing, and number of pills dispensed.
We defined anti-secretory medications (e.g., histamine-2
receptor antagonists (H2 blocker) or proton pump in-
hibitors (PPI)) using data from the year prior to control
selection (the reference dates).
Population controls
Population controls were randomly selected from among
members of the entire KPNC membership at the time
the Barrett’s esophagus cases were identified. Individuals
with Barrett's esophagus were excluded. For the current
study, we also excluded population controls who, upon
interview, reported heartburn or acid regurgitation once
a month or more.
Measurements of dietary intake
All study subjects completed: an in-person interview
(most commonly at the subject’s home) of GERD symp-
toms, medication use, medical history, diet, tobacco
use and alcohol use; phlebotomy; and anthropometric
measurements.
We assessed dietary intake using a validated 110-item
food frequency questionnaire (FFQ) [21-24]. This ques-
tionnaire estimates average daily nutrient intake based on
questions about frequency and portion size of a given food
and usual eating habits for the year before the index date
[25]. Dietary data were translated to daily intakes of spe-
cific nutrients using NutritionQuest (Berkeley, CA), and
the raw data were used to estimate weekly consumption of
particular food items. We excluded subjects with over 20
missing food items or with extremely high (>6000 kcal/
day) or low (<400 kcal/day) total daily energy intakes.
We evaluated the associations between consumption
of commonly discussed “reflux-triggering” dietary factors
based on recommendations from the American College
of Gastroenterology [17], National Institute of Health [18],
and food items that have been studied in previous clinical
research of GERD [26,27]. Among those food items, data
were available in our questionnaire for: coffee, tea, soft
drinks, alcohol (total, wine, beer, and liquor), citrus, to-
mato products, total fat, fried foods, and large portion
meals. “Soft drink” consumption was used as the proxy for
“carbonated drinks” in the data; the questionnaire did not
include diet sodas. Coffee and tea consumption did not
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excluded herbal tea. The food items and nutrients in-
cluded total fat; fried foods (e.g., French fries, fried
chicken, fish, and doughnuts); tomato products (e.g., fresh
tomatoes, canned tomatoes, and tomato juice); and citrus
(fruits and juice). The measurement units were mostly
“servings per week”, except for fat (grams/day), coffee and
tea (cups/day) and alcohol (drinks/day). The term ‘drink’
for alcohol was defined as: wine (7-8 oz), beer (12 ounces),
liquor (one shot). Portion size reporting was facilitated by
pictures depicting small (1/4 cup), medium (1/2 cup),
large (1 cup), and extra-large (2 cups) servings. In this
study, each person was scored on the proportion of foods
that were reported as large or extra large. For instance, if a
person indicated that half of what he/she consumed was
in large or extra-large portions (1–2 cups), the person was
considered to consume 50% of the meal in large portion.
On the other hand, if a person always consumed small or
medium portion meals (1/4-1/2cup), the person was cate-
gorized to consume 0% of the meal in large portion.
We constructed tertile categories for items with a nor-
mal distribution, such as fat intake and portion size. For
most other food items, the distributions were skewed with
large number of subjects consuming none of the item. For
those items, intakes were categorized as follows: zero in-
take (referent), low intake, and high intake. Tertile cutoff
points were chosen a priori (prior to analysis) to create
relatively even distributions of population controls.
Measurements of GERD symptoms
GERD symptoms were defined as either heartburn (a
burning pain or discomfort behind the breastbone) or
acid regurgitation (a bitter or sour-tasting fluid coming
up into the throat or mouth) using a validated question-
naire [28]. Symptom severity was recorded as either mild
(could be ignored), moderate (could not be ignored, but
didn’t affect lifestyle), severe (could not be ignored and did
affect lifestyle), or very severe (markedly affected lifestyle).
Symptom frequency was coded as: less than once a month,
less than once a week (but more than once a month), once
or more a week, or daily. For the analysis of severity, we
compared individuals who had moderate to severe symp-
toms (with at least monthly frequency) to asymptomatic
population controls, and excluded individuals with mild
severity (N = 75). For frequency analysis, we compared
two categories (GERD symptoms greater than several
times a week; more than once a month to once a week) to
asymptomatic population controls.
Statistical analysis
We evaluated whether GERD was associated with the in-
take of certain beverages, nutrients, or food items using
unconditional logistic regression to calculate odds ratios
(ORs) as an estimate of the relative risk with GERDstatus as an independent variable and dietary factors as
the dependent variable [29]. We evaluated the following
additional variables as potential confounders: race/
ethnicity (classified as white vs. non-white due to small
sample sizes in the race/ethnic subgroups), smoking (ever
vs. never and current vs. never), body mass index (BMI,
kg/m2), medical center, recent alcohol use (number of
drinks per week), aspirin or nonsteroidal anti-inflammatory
drug (NSAID) use, a comorbidity index (the DxCg score)
[30,31], education, income, serum Helicobacter Pylori
(H. Pylori) antibody status, and energy consumption
(kcal/day). Confounders were included in the final model
if their inclusion altered the odds ratio by >10% [29].
We evaluated for interaction by gender, race, long-term
(2 + years) vitamin supplement use, NSAIDs use, H. pyl-
ori, or regular use (at least once a week) of GERD medi-
cation (antacid, H2 blocker, or PPI) using cross product
terms in the logistic regression model and stratified
analysis. All analyses were performed using STATA stat-
istical software (College Station, TX).
Results
Study population
Of the 316 GERD patients and 317 population controls
from the original study, dietary data were available for
622 subjects (98% of interviewed subjects). Exclusion of
six subjects with extreme values of caloric intake or ≥6
missing values on the food questionnaire and 126 popula-
tion controls who reported acid regurgitation or heartburn
more than once per month provided 308 GERD patients
and 182 GERD-free population controls (Tables 1 and 2).
The proportions of smokers and individuals who con-
sumed large or extra-large portion sizes were similar
between the groups.
Beverage choice and gastroesophageal reflux symptoms
Patients with moderate to severe GERD symptoms were
over twice as likely as GERD-free controls to consume soft
drinks, adjusting for smoking and education [OR = 2.11,
95% CI:1.16-3.84] (Table 3); there was no association with
GERD frequency (Table 4).
Patients with moderate to severe GERD symptoms
were also more likely to consume one or more cups of
regular tea a day compared to asymptomatic controls
[OR = 1.86; 95% CI:1.16-2.97 for severe GERD]. There
was no association between GERD symptom severity or
frequency and coffee consumption.
GERD patients with severe or frequent symptoms were
less likely to consume beer, and there was also an inverse
association between GERD symptom severity and general
alcohol drinking, especially light drinking. For instance,
patients with moderate to severe symptoms were almost
half as likely to drink beer as those without GERD [OR =
0.54 95% CI 0.31-0.96]. Similarly, patients with frequent
Table 1 Characteristics of study groups
GERD Group
(physician-assigned)
Population controls
without GERD1
Number or Mean
(% or standard
deviation)
Number or Mean
(% or standard
deviation)
Number of subjects 308 182
Age (years)
20-39 11 (4) 9 (5)
40-59 111 (36) 63 (35)
60-79 186 (60) 110 (60)
Race/Ethnicity
White 247 (80) 154 (84)
Black 20 (6) 10 (5)
Hispanic 20 (6) 7 (4)
Asian 8 (3) 5 (3)
Others/Missing/
Unknown
13 (4) 6 (3)
Male 211 (69) 123 (68)
GERD symptoms
Severity2
Severe & very severe 124 (40) –
Moderate 109 (35) –
Mild 75 (25) –
Frequency
Daily 78 (25) –
Several times a week 89 (29) –
Once month – once a
week
91 (30) –
Less than once a
month
50 (16) –
BMI 28.9 (5.2) 28.3 (5.5)
Smoking
Current smoker 30 (10) 19 (10)
Portion size
% extra large or large 27.9 (16.3) 28.8 (17.2)
1Self-reported heartburn or acid reflux <1/month.
2Severity with at least monthly or less than once a month frequency.
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beer [OR = 0.52 95% CI: 0.28-0.96]. There were non-
significant, though positive association between GERD
symptom severity and frequency and liquor drinking:
individuals with severe GERD symptoms were 50%
more likely to drink liquor compared to those without
GERD [OR = 1.50 95% CI: 0.85-2.66].
Food, total fat, portion size and gastroesophageal reflux
symptoms
Patients with severe or frequent GERD symptoms were less
likely to consume citrus fruits compared to asymptomaticcontrols [OR = 0.62; 95% CI: 0.41-0.94; OR = 0.62; 95% CI:
0.40-0.98, respectively]. On the other hand, there was no
association between the severity or frequency of GERD
symptoms and consumption of tomato products, another
acidic food which GERD patients are recommended to
avoid (Tables 3 and 4).
Individuals with severe symptoms had higher total fat
consumptions than those without GERD [OR = 1.77 95%
CI: 1.07-2.93 for highest tertile; OR = 1.67 95% CI: 1.03-2.71
for second tertile]. Similar associations were observed for
frequency of GERD symptoms and total fat. In addition,
individuals with frequent symptoms were twice as likely
to consume fried foods [OR = 2.10; 95% CI: 1.19-3.70
for most frequent; OR = 1.87 95% CI: 1.00-3.52 for
monthly-weekly frequency]. There was no association
between the severity or frequency of GERD symptoms
and large portion sizes.Supplementary analyses
Composite severity and frequency GERD and diet
To evaluate the dietary habits of individuals with severe
and frequent GERD symptoms, we created a composite
variable including those with moderate to severe symp-
toms with at least weekly frequency and compared with
asymptomatic controls. Most of the individuals who
were in the moderate to severe category overlapped with
this composite category (120/124 = 97%), and the results
were similar to those presented in Table 3, though the
associations strengthened slightly. For instance, indi-
viduals with severe and frequent symptoms were twice
as likely as controls to consume soft drinks or tea [OR =
1.98 95% CI: 1.18-3.31; OR = 2.16 95% CI: 1.15-4.03,
respectively].Effect modification
The association between soft drink consumption and
GERD severity was stronger among women [OR = 5.71
95% CI 1.75-18.66] than among men [OR = 1.55 95% CI:
0.75-3.23].Analysis of potential confounding
There was no evidence of strong confounding by age,
gender, ethnicity, BMI, NSAIDS, alcohol use, income,
total energy, facility of diagnosis, income, co-morbidity
score, long-term vitamin supplement use, or serum H.
pylori antibody status. A fully adjusted model for citrus
intake vs. moderate to severe GERD symptoms (contain-
ing all these factors plus education and smoking), for
example, produced effect estimates [OR = 0.56; 95% CI:
0.29-0.77] similar to a model that contained only educa-
tion and smoking [OR = 0.62; 95% CI: 0.41-0.94]. The
results were similar for other dietary variables.
Table 2 Mean intake between physician-assigned GERD patients and population controls with no or little reported
symptoms
GERD Group (physician-assigned) Population controls without GERD1
Number or Mean
(% or standard deviation)
Number or Mean
(% or standard deviation)
Number of subjects 308 182
Beverages
Soft drinks (servings/week) 3.2 (6.7) 2.1 (5.4)
Coffee (cups/day) 8.7 (10.4) 9.9 (9.9)
Tea (cups/day) 4.1 (7.4) 2.9 (5.2)
Alcohol (drinks/day)
Non drinker 109 (35) 41 (23)
<=1/day 128 (42) 91 (50)
>1 & <2/day 29 (9) 31 (17)
> = 2/day 42 (14) 19 (10)
Nutrients/food items
Calories (kcal/day) 1828 (770) 1797 (776)
Total fat (g/day) 77.9 (37.9) 77.5 (39.6)
Fried foods (fried potatoes, chickens, fish, doughnuts-servings/week) 0.7 (1.5) 0.6 (1.1)
Tomato products (servings/week) 1.5 (2.8) 1.5 (2.3)
Citrus (citrus fruits + juice- servings/week) 2.3 (3.8) 2.8 (3.5)
1Self-reported heartburn or acid reflux <1/month.
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The current study, to our knowledge, is the first popula-
tion or community-based study to assess whether pa-
tients with GERD adhere to dietary guidelines that are
often recommended as a part of non-pharmacological,
lifestyle modification to reduce their symptoms [17,18].
Patients with severe or frequent GERD symptoms were
less likely to consume citrus and beer and more likely to
consume tea, soft drinks, total fat, and possibly liquor.
There was no association between portion size, tomato
products, coffee and GERD severity or frequency.
Our study extends the existing knowledge regarding
the relationship between GERD symptoms and dietary
intake. First, our data demonstrate that patients with
more severe or frequent reflux symptoms are less likely
to consume citrus. Citrus and other acidic foods such as
tomatoes are often considered reflux-triggering. A previ-
ous clinical study reported that acid-sensitive patients
were sensitive to intraesophageal infusion of orange or
tomato juice, even when the pH of juice was adjusted to
neutral [32], suggesting that some other component in
citrus or tomato beside acidity may affect the symptoms.
We cannot assess from our data whether the patients in
our study avoided citrus (but not tomato products) be-
cause they actually worsened their symptoms or because
of perceived stronger recommendations to avoid citrus
than tomato products.Our results suggest that individuals with severe GERD
symptoms are less likely to drink beer but more likely to
drink liquor. Alcohol ingestion is thought to induce
GERD by reducing lower esophageal sphincter pressure,
increasing acid secretion through gastrin stimulation,
decreasing esophageal motility and impairing gastric
emptying [33-36]. Multiple differences exist between
beverage types including alcohol content (lower in beer),
volume (higher per serving for beer), and carbonation
(present in beer but not liquor). These differences may
partially explain the alcohol choices found in GERD pa-
tients, although we cannot exclude confounding by other
factors, since liquor drinkers may differ from beer drinkers
in many ways.
Patients with moderate to severe GERD symptoms
were more likely to drink soft drinks than controls. Soft
drinks, often carbonated, may result in a very short de-
cline in intra-esophageal pH and transient reduction in
lower esophageal sphincter basal pressure [37]. A recent
small clinical experiment demonstrated that in healthy
individuals, ingestion of carbonated water, caffeinated cola,
or caffeine-free cola reduced lower esophageal sphincter
pressure compared with tap water ingestion [38]. A multi-
center, longitudinal, cohort study of the cardiovascular
consequences of sleep-disordered breathing reported that
carbonated soft drink consumption was a major pre-
dictor of nocturnal heartburn [39]. Our data suggests
Table 3 Association between moderate to severe GERD
symptoms and intake of certain food items, comparing
patients with moderate to severe symptoms to GERD-free
population controls
Severity Moderate to severe GERD symptoms
N OR1 95% CI
Case Control
Softdrinks2
None 70 86 1.0 (ref)
>1/week 84 57 1.86 1.16 2.97
Coffee3
None 92 55 1.0 (ref)
2+/day 72 44 0.89 0.52 1.51
Tea4
None 44 61 1.0 (ref)
1+/day 51 41 1.86 1.02 3.40
Alcohol5
None 116 57 1.0 (ref)
<1 drink/day 74 70 0.56 0.35 0.90
1+ drink/day 48 70 0.83 0.46 1.48
Wine
None 72 86 1.0 (ref)
1 + glass/day 49 94 0.74 0.45 1.23
Beer
None 53 99 1.0 (ref)
1 + drink/day 29 101 0.54 0.31 0.96
Liquor
None 31 126 1.0 (ref)
1 + shot/day 36 99 1.50 0.85 2.66
Citrus
<2servings/week 106 125 1.0 (ref)
2+/week 59 133 0.62 0.41 0.94
Tomatoes
None 55 176 1.0 (ref)
1+/week 48 144 1.10 0.70 1.75
Fried foods
<1serving/week 42 189 1.0 (ref)
1+ 49 143 1.52 0.94 2.45
Total fat
1st Tertile (<57 g/day) 67 88 1.0 (ref)
2nd Tertile 50 76 1.67 1.03 2.71
3rd T >90 g/day 66 52 1.77 1.07 2.93
Table 3 Association between moderate to severe GERD
symptoms and intake of certain food items, comparing
patients with moderate to severe symptoms to GERD-free
population controls (Continued)
Portion size
<20% large portion 58 83 1.0 (ref)
40 +% 55 56 1.30 0.78 2.19
1Models are adjusted for smoking and education.
2Not including diet soda.
3Includes both caffeinated and decaffeinated types.
4Excludes herbal tea.
5Excludes individuals who are occasional drinkers (more than once a year but
less than one drink/week).
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patients do not avoid its consumption.
This study has potential limitations. First, cross-
sectional studies cannot establish cause and effect [29].
The inverse associations, such as the avoidance of citrus
among GERD subjects, could be because such foods
cause GERD symptoms (so the subject avoids them), be-
cause patients adhere to the dietary guidelines even if
avoidance is not completely ineffective, or even conceiv-
ably because the absence of such foods causes GERD
(and the reason the person has GERD is because they
don’t consume them), although the latter possibility
seems less likely for the foods studied. In contrast, the
positive association between soda consumption and
GERD symptoms, for example, could be either from soft
drinks causing the greater GERD symptoms or, alterna-
tively, patients actually drinking soda to relieve their
GERD symptoms, despite the reported adverse mechan-
istic associations. However, if the association is true
(GERD patients drink more soft drinks than controls
and soft drinks worsen symptoms), then it may indicate
that GERD patients may benefit from enhanced dietary
modification. Second, the GERD patients evaluated, by
study definition, had a physician-assigned diagnosis of
GERD and had previously received anti-secretory medi-
cations. This population may represent patients with
more severe GERD symptoms than a general population
sample; however, it also represents patients who, if med-
ications have potential for harm, may benefit most from
nonpharmacologic treatments (if they are effective).
Third, some of the dietary information obtained for this
study was not complete. For instance, we did not have in-
formation on types of coffee (decaffeinated or regular).
Strengths of the present study include its community-
based design, random sampling of patients from the
population base (rather than convenience sampling of
clinic-based patients), use of a validated food frequency
questionnaire and a validated GERD questionnaires for
symptom frequency and intensity, in person interviews
for GERD symptoms, the availability of high quality
interview and laboratory data for multiple confounders,
Table 4 Association between the frequency of GERD symptoms and intake of certain food items (GERD patients vs.
no-GERD population controls)
Frequency > = Several times/week Once a month to once a week
N OR1 95% CI N OR1 95% CI
Case Control Case Control
Softdrinks2
None 46 50 1.0 (ref) 46 50 1.0 (ref)
>1/week 97 70 1.54 0.93 2.58 31 47 0.75 0.41 1.39
Coffee3
None 56 37 1.0 (ref) 56 37 1.0 (ref)
2+/day 83 53 0.98 0.56 1.72 47 27 1.25 0.65 2.39
Tea4
None 29 36 1.0 (ref) 29 36 1.0 (ref)
1+/day 57 50 1.54 0.81 2.93 20 37 0.70 0.34 1.47
Alcohol5
None 72 31 1.0 (ref) 72 31 1.0 (ref)
<1 drink/day 91 82 0.51 0.30 0.85 56 36 0.69 0.38 1.26
1+ drink/day 53 82 0.68 0.35 1.30 30 37 0.88 0.42 1.85
Wine
None 48 51 48 51 1.0 (ref)
1 + glass/day 56 111 0.64 0.37 1.10 36 47 1.02 0.54 1.91
Beer
None 31 57 1.0 (ref) 31 57 1.0 (ref)
1 + drink/day 35 120 0.52 0.28 0.96 28 59 0.89 0.46 1.71
Liquor
None 19 74 1.0 (ref) 19 74 1.0 (ref)
1 + shot/day 43 120 1.44 0.77 2.70 17 70 1.07 0.51 2.26
Citrus
<2servings/week 63 78 1.0 (ref) 63 78 1.0 (ref)
2+/week 69 118 0.62 0.40 0.98 55 132 1.03 0.62 1.69
Tomatoes
None 28 113 1.0 (ref) 28 113 1.0 (ref)
1+/week 55 171 1.35 0.80 2.28 31 91 1.44 0.80 2.59
Fried foods
<1serving/week 20 121 20 121 1.0 (ref)
1+ 59 167 2.10 1.19 3.70 29 93 1.87 1.00 3.52
Total fat
1st Tertile (<57 g/day) 48 57 1.0 (ref) 48 57 1.0 (ref)
2nd Tertile 88 67 1.57 0.94 2.62 40 38 1.27 0.70 2.31
3rd T >90 g/day 71 70 1.69 0.98 2.91 44 40 1.89 1.03 3.47
Portion size
<20% large portion 33 52 1.0 (ref) 33 52 1.0 (ref)
40 +% 61 71 1.23 0.75 2.02 33 43 1.01 0.57 1.77
1Models are adjusted for smoking and education.
2Not including diet soda.
3Includes both caffeinated and decaffeinated types.
4Excludes herbal tea.
5Excludes individuals who are occasional drinkers (more than once a year but less than one drink/week).
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we used a well characterized population of GERD pa-
tients confirmed by both self-report and a physician
diagnosis. The combination of these features provides a
high quality evaluation of the associations within the
limits of an observational study. Subjects came from a
diverse KPNC membership base that closely approxi-
mates the region’s census demographics, and the results
can likely be generalized to similar large populations.Conclusions
In summary, to our knowledge, this is the first large,
community-based U.S. population to evaluate whether
GERD patients adhere to the dietary guidelines com-
monly recommended for GERD patients. We found that
while GERD patients, consistent with dietary recommen-
dations, are less likely to consume citrus and certain
types of alcohol, they were more likely to consume soft
drinks, tea, and fatty foods than asymptomatic controls.
The results suggest that GERD patients do avoid some,
but not all, of the foods commonly thought to worsen
GERD symptoms. Given the prevalence of GERD symp-
toms and the emergence of possible adverse effects of
long-term gastric acid inhibition, more studies, particu-
larly randomized clinical trials on the effectiveness of
dietary modification, are needed to better understand
the role of nonpharmacologic approaches, such as diet-
ary modification, in the treatment of GERD.
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